Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Peptide radioreceptor therapy (PRRT) is a promising therapy option for SSTR2-positive pancreatic neuroendocrine neoplasms (NEN). However, therapeutic effects are often not satisfying concerning sensitivity to PRRT. We hypothesize that the slow proliferation of NENs provides sufficient time for the repair of beta-particle induced-DNA damage. The ubiquitin-proteasome-system is involved in DNA damage repair and affected by the proteasome inhibitor bortezomib (Velcade®). The inhibition of DNA damage repair during PRRT may be an option to improve therapy response in NEN. We have recently demonstrated the damage repair inhibitory and pro-apoptotic effect of bortezomib in NEN in vitro (Briest et al., in revision).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Briest F
Authors: Briest F, Grötzinger C, Exner S, Sedding D, Baum R,
Keywords: peptide radioreceptor therapy, Lu-177-DOTATOC, PRRT, bortezomib, in vivo model, SPECT/CT Imaging, chicken CAM model, Sensitizer, DNA damage repair,
Introduction: Liver transplantation (LT) is offered to selected patients of neuroendocrine tumours (NETs) with unresectable liver metastases (NELM).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Pande P
Authors: Pande P, Desai G, Shah R, Palepu J,
Keywords: : neuroendocrine tumours, liver metastases, liver transplantation,
Introduction: The development of new therapeutic strategies for cancer patients relies on the in vitro and in vivo testing of novel substances in the pre-clinical setting. So far, this has not been possible for pancreatic neuroendocrine tumors (pNET) due to lack of suitable animal models resembling the disease course in human patients.
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Schrader J, Unrau L, Stahl F, Eggers C, Fahl M,
Keywords: pNET, insulinoma, SSTR,
Introduction: Patients with advanced neuroendocrine tumors (NETs) benefit from an increasing number of treatments. The patient’s preference could help physicians to choose among these options
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author: Thomas W
Authors: Plante A, Baudin E, Do Cao C, Hentic O, Dubreuil O,
Keywords: neuroendocrine tumor, toxicity, PRO,
#1552 Liver Transplantation for Gastroenteropancreatic Neuroendocrine Tumors
Introduction: Neuroendocrine tumors (NET) are rare neoplasms and liver transplantation (LT) for hepatic metastases is indicated in selected cases where other therapies have failed.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Figueira E
Authors: Figueira E, Rocha Filho J, Haddad L, Oliveira A, Okubo J,
Keywords: Liver transplant, metastasis,